Receive the latest news 
straight to your inbox
Learn more
CF AMR Syndicate Research into AMR
On this page:

New Therapeutics to treat lung infections in CF

As part of the first funding call for CF AMR which is now closed, we were looking to help create and advance an exciting and diverse pipeline of preclinical phase projects aimed at treating lung infections in people with Cystic Fibrosis.

In 2023, we launched a new programme, the Collaborative Discovery Programme. The first funding call associated with this programme was entitled: New Therapeutics to treat lung infections in CF. The £3 million fund (provided by LifeArc) will support up to 5 early-stage drug discovery projects that seek to develop new therapeutics to treat lung infections in CF.

Unlike typical grant funding, we offer a truly collaborative approach to project development and delivery. Our intention is not just to fund but to add additional collaborative support and advice to enable the best chances of success for the project.

Eligibility

The first funding call was open to researchers in academia and small and medium enterprises (SMEs) worldwide. Projects will be milestone-driven and expected to last up to 2 years, with total project costs of up to £500,000.

Collaborative Discovery Programme Awardees

See the awardees

Webinar

Agenda

  • Opening Remarks and Introduction to the CF AMR Syndicate – Dr. Katy Kettleborough & Dr Paula Sommer
  • Living with CF – A Personal Perspective – Angelo Micciche
  • The need for new antimicrobials in CF & what good looks like – Target Product Profiles – Prof. Jane Davies
  • The Collaborative Discovery Programme: Funding Call Overview – Dr. Neill Gingles & Dr. Ed McIver
  • Interactive Q&A – CF AMR Syndicate Management Team

 

Application process

The expression of interest is now closed and final funding decisions have been made as the funding call is closed. Key steps in the application process are summarised.

30 March

Expressions of Interest opened with a webinar

09 May

Deadline for Expression of Interest

Early June

Selected applicants were invited to full application

28 July

Deadline for full application

View more

Meet the team
Managing Partners
About Cystic Fibrosis